A Disorder of Ki: Alternative Treatments for Neurasthenia In

Total Page:16

File Type:pdf, Size:1020Kb

A Disorder of Ki: Alternative Treatments for Neurasthenia In A DISORDER OF KI ALTERNATIVE TREATMENTS FOR NEURASTHENIA IN JAPAN, 1890-1945 Yu-Chuan Wu University College London PhD 1 I, bk~ Wu , confirm that the work presented in this thesis is my own. Where information has been derived from other sources, I confirm that this has been indicated in the thesis. 2 Abstract This thesis studies some of the most popular alternative treatments for neurasthenia in Japan in the period of 1890 to 1945, including breathing exercise, quiet-sitting, hypnotism-derived mental therapy and Morita therapy. Neurasthenia, with its supposed relation to modern civilization, was a widely used and preferred disease label in Japan. As the official Western medicine failed to provide satisfactory solutions to this obstinate and debilitating disease, a variety of alternative treatments were invented or reinvented and some of them became very popular. Concerning the popularity and effectiveness of these treatments, this thesis argues that they provided contemporary Japanese, who had been experiencing rapid and dramatic change to lifestyle, culture and society, with models by which they could perceive, conceive and strengthen their neurological, circulatory and psychological systems by their analogy to ki. Known as a nervous disorder, neurasthenia was also perceived and understood as a disorder of ki, with insufficiency, stagnation, obstruction and turbulence still thought to be the major faults. Through undergoing and practicing these treatments, Japanese neurasthenic patients could control and invigorate the flow of nervous currents, blood and ideas as they previously cultivated ki. This thesis also investigates these treatments in the context of Japanese nationalism. Their advocates often claimed that they were embedded in traditional Japanese culture and hence particularly effective for Japanese patients. Returning to traditional lifestyle and culture was regarded by them as a cure for neurasthenia, which they thought was a disease of ‘de-Japanization’. Furthermore, they founded a large number of groups and organizations for the practice and promotion of these treatments, which were in many ways like traditional extended families and provided patients with a much-needed sense of security and belonging. These treatments were endowed with social and cultural significance, which was also crucial to their therapeutic effectiveness for neurasthenia. 3 Contents Introduction The Effectiveness of Psychotherapy 7 Neurasthenia: A Nervous Disorder 10 Neurasthenia: A Psychological Disorder 20 Neurasthenia in Japan 26 1. The Abdominal Heart Neurasthenia and its Recovery 38 Neurasthenia: a Disease of Top-heaviness 46 Modern Lifestyle: A Lifestyle of Top-heaviness 56 Abdominal Heart: Futaki’s ‘Abdominal Breathing’ 65 Fujita’s ‘Belly-centred Medicine’ and Okadaian Quiet-Sitting 74 ‘Modernization’ of Breathing exercise and Quiet-sitting 83 2. A Civilization of the Belly Two Different Kinds of Bodies 86 Breathing Exercise, Ki and Yōjō Medicine 88 Modern Forms of Ki 93 Nostalgia, De-Japanization and the ‘Japanese’ Belly 101 ‘Teacher!’ 114 Modern Forms of Breathing Exercise 120 ‘Modern’ or ‘Traditional’? 125 3. Mental Therapy Mental Therapy and Mental Therapists 128 Hypnotism in Japan: 1880 – 1913 133 No Idea, No Thought, No Self and No Mind 140 Neurasthenia: the Stagnant flow of Ideas and Obsessions 150 Body and Mind: the Flow of Ki and the Flow of Attention 158 College, Family and Nation 171 Body, Mind and Spirit 183 4 4. Morita Therapy Morita Therapy: A Modern Form of Psychotherapy? 187 What is Morita Therapy? 191 Shinkeishitsu 198 Renunciation of the Ego 205 The Flow of the Mind and Attention 211 A Family of Shinkeishitsu 221 A Nation of Shinkeishitsu 233 Epilogue Is the Ki still Flowing? 244 Bibliography References to works in Japanese 249 References to works in English 292 5 A note on translations: All translations, including book titles, from the Japanese are by the author, except where otherwise indicated. 6 Introduction The Effectiveness of Psychotherapy What underlies the effectiveness of psychotherapy? This question lies at the foundation of clinical psychology. Although the psychotherapeutic profession insists that modern psychotherapy is soundly based on psychological knowledge, it has often been the case that the development of a form of psychotherapy comes well before that of the theory upon which it is allegedly based. From hypnotism and moral persuasion to catharsis and free association, the effectiveness or ineffectiveness of treatments has been the key subject of speculation and research for psychiatrists and clinical psychologists. The efforts made to solve the puzzle have resulted in a host of theories about the mind and its disorders, which not only constitute the theoretical basis of this discipline but also profoundly influence how people understand themselves. However, the effectiveness of psychotherapy has been precarious and elusive. Often, a form of therapy effective in a particular historical, social and cultural context loses its healing effect when carried out in other environments. Even in a particular time and place, the effectiveness can vary widely among individual clients who come from various walks of life and have different life stories. In the history of psychological medicine, there have been several forms of psychotherapy, such as hypnotism, whose acknowledged efficacy varied across era, society and culture and whose popularity rose and fell again and again. To explain the effectiveness, psychiatrists and psychologists continually invent new psychological or somatic theories, which are sometimes consistent with, sometimes parallel to, or, not infrequently, completely contradictory to one another. Nonetheless, they form the theoretical foundation of modern psychotherapeutics. Psychiatrists, psychologists and psychotherapists seem to have agreed on the varying effectiveness of psychotherapy and the diversity and inconsistency of its theories. An eclectic approach seems inevitable for a discipline and profession that has been built upon something as precarious as the effectiveness of psychotherapy; the technology and knowledge of psychological medicine have hence often been subjected to doubt and criticism, 7 as well as modification. But the contingency and elusiveness of the effectiveness of psychotherapy should not be surprising, since psychotherapy is meant to treat mental diseases, particularly non-psychotic mental diseases, that have been equally, if not more, changeable and elusive. Take a look at the diseases that gave rise to the birth of modern psychotherapy in the late nineteenth and early twentieth centuries. Modern psychotherapy came into being to treat diseases from hysteria and neurasthenia to fugue and multiple personality, and their supposed underlying psychopathological mechanisms were assumed to be the targets of psychotherapy. These diseases, once prevalent in particular places and with particular people, have all but vanished into history and are rarely seen by today’s psychiatrists and psychotherapists. Only the various forms of psychotherapy originally invented to treat them continue to exist and develop to deal with new mental diseases that have taken their place. The objects of psychotherapy have changed remarkably over time, so it is understandable that there is no sound or durable explanation of its efficacy in the past or today Perhaps the effectiveness of psychotherapy needs to be explored from a different perspective, just as those diseases that once were its primary objects do. Although no longer a concern for today’s psychiatrists and psychotherapists, these diseases, central to the foundation of modern psychiatry and clinical psychology, have become interesting to historians of psychiatry and psychology. With hindsight, historians are able to focus their study on the historical nature of these elusive diseases, as well as that of the various theories invented to explain them. By investigating these diseases and theories in a wider context, historical studies have made it clear that not only did contemporary intellectual, social, cultural and political situations, such as intellectual traditions and trends, gender and class issues and ongoing social and political conflicts, greatly influence how doctors, patients and the public viewed, understood and responded to these diseases, but their occurrence, presentation, distribution and disappearance can also be better understood in context than by any somatic, psychological or social causes alone.1 Holding different views on their biological and 1 Ian Hacking, Mad Travelers: Reflections on the Reality of Transient Mental Illnesses (London, 1998); Mark S. Micale, Approaching Hysteria: Disease and its Interpretations (Princeton, N.J., 8 psychological reality, historians explored these diseases as historical realities to see how they evolved in history. They have provided valuable insights into a wide range of questions related to these diseases, including those that had always been the focus of psychiatric and psychological study, such as why they were epidemic and presented with certain symptoms in certain times and places, and why certain genders, classes and groups of people were overrepresented in the patient populations. Whether or not they have biological or psychological basis, the features presented by these diseases are, to a great extent, historical ones and have to be understood in history. A wide range of factors, not just psychological ones, gave rise to, sustained and eventually led to the disappearance
Recommended publications
  • A Case–Control Study of Erectile Dysfunction Among Men Diagnosed with Panic Disorder
    International Journal of Impotence Research (2004) 16, 299–302 & 2004 Nature Publishing Group All rights reserved 0955-9930/04 $30.00 www.nature.com/ijir Case Report A case–control study of erectile dysfunction among men diagnosed with panic disorder WA Blumentals1*, A Gomez-Caminero1,*, RR Brown1, V Vannappagari2 and LJ Russo1 1Worldwide Epidemiology, GlaxoSmithKline Pharmaceuticals, Collegeville, Pennsylvania, USA; and 2Department of Epidemiology, University of North Carolina at Chapel Hill, McGavran-Greenberg Hall, Chapel Hill, North Carolina, USA The association between panic disorder and erectile dysfunction (ED) among men was examined in the Integrated Healthcare Information Services National Managed Care Benchmark Database (IHCIS). The IHCIS is a fully de-identified, HIPAA compliant database and includes complete medical history for more than 17 million managed care lives; data from more than 30 US health plans, covering seven census regions; and patient demographics, including morbidity, age and gender. A total of 60 949 ED cases and 243 796 controls were included for analysis. Unconditional logistic regression analyses were first performed to assess the crude risk of ED, and adjusted risks of ED that accounted for comorbid conditions and comedications. A second set of analyses measured the crude and adjusted risks after restricting the patient population to men who were diagnosed with panic disorder at least 1 month prior to an ED diagnosis. In the first set of analyses, men with panic disorder were observed to have more than a two-fold increase in risk for ED (OR ¼ 2.29, 95% CI ¼ 2.03, 2.58). After adjusting for comorbid conditions, a 52% increase in risk of ED was observed (OR ¼ 1.52, 95% CI ¼ 1.34, 1.72).
    [Show full text]
  • Neurasthenia in a Longitudinal Cohort Study of Young Adults
    Psychological Medicine, 1994, 24, 1013-1024. Copyright © 1994 Cambridge University Press Neurasthenia in a longitudinal cohort study of young adults K. MERIKANGAS1 AND J. ANGST From the Genetic Epidemiology Research Unit, Yale University School of Medicine, New Haven, CT, USA; and Psychiatric University Hospital, Zurich, Switzerland SYNOPSIS This study examines the concept of neurasthenia in a longitudinal cohort of young adults selected from a community sample of the canton of Zurich, Switzerland. The major focus is on the validity of the case definition of neurasthenia. Close approximations of the proposed descriptive and research definitions of the ICD-10 are employed as well as the concept of'irritable weakness' as described in 1831 by Kraus (1926-1932). The prevalence of neurasthenia defined according to the ICD-10 criteria was: 1 % across 10 years and 0-9% in 1988 for a duration criterion of ^ 3 months; and 81 % across 10 years and 12% in 1988 for a duration criterion of ^ 1 month. The duration criterion of ^ 3 months appeared to be excessively restrictive to represent individuals with neurasthenia in the community. Subjects with 1 month episodes of neurasthenia exhibited sufficient differences from controls and similarities to subjects with anxiety or depressive disorders to justify a 1 month duration criterion for neurasthenia in community samples. The clinical significance of neurasthenia was indicated by the magnitude of subjective distress, and occupational and social impairment reported by the majority of the cases. Prospective assessment of the longitudinal course of neurasthenia revealed that approximately 50 % of the cases continued to exhibit this disorder at follow-up.
    [Show full text]
  • Evidence Report: Risk of Adverse Cognitive Or Behavioral Conditions
    Evidence Report: Risk of Adverse Cognitive or Behavioral Conditions and Psychiatric Disorders Human Research Program Behavioral Health and Performance Approved for Public Release: April 11, 2016 National Aeronautics and Space Administration Lyndon B. Johnson Space Center Houston, Texas 1 CURRENT CONTRIBUTING AUTHORS: Kelley J. Slack, Ph.D. Wyle Science Technology & Engineering Thomas J. Williams, Ph.D. Wyle Science Technology & Engineering Jason S. Schneiderman, Ph.D. Wyle Science Technology & Engineering Alexandra M. Whitmire, Ph.D. Wyle Science Technology & Engineering James J. Picano, Ph.D. Universities Space Research Association PREVIOUS CONTRIBUTING AUTHORS: Lauren B. Leveton, Ph.D. NASA Johnson Space Center Lacey L. Schmidt, Ph.D. Minerva Work Solutions Camille Shea, Ph.D. Houston Police Department 2 TABLE OF CONTENTS I. PRD RISK TITLE: RISK OF ADVERSE COGNITIVE OR BEHAVIORAL CONDITIONS AND PSYCHIATRIC DISORDERS ............................................................................................. 6 II. EXECUTIVE SUMMARY .................................................................................................... 9 III. INTRODUCTION ................................................................................................................ 11 IV. EVIDENCE ........................................................................................................................... 14 A. Space Flight Evidence .................................................................................................... 17 1. Sources
    [Show full text]
  • Neurology A.N
    Postgrad Med J (1991) 67, 509 - 531 i) The Fellowship of Postgraduate Medicine, 1991 Postgrad Med J: first published as 10.1136/pgmj.67.788.509 on 1 June 1991. Downloaded from Reviews in Medicine Neurology A.N. Gale, J.M. Gibbs, A.H.V. Schapira and P.K. Thomas Department ofNeurological Science, Royal Free Hospital School ofMedicine, RowlandHill Street, London NW3 2PF, UK Introduction The past few years have seen a significant improve- gitis, Tunkel et al.' point out that the mortality has ment in our ability to diagnose and treat neuro- not changed significantly over the last 30 years but logical diseases. New imaging techniques such as the prognosis for Gram-negative meningitis has computed tomographic (CT) scanning and magne- been markedly improved by the introduction of tic resonance imaging (MRI) have had a major third generation cephalosporins. impact on the practice ofneurology. Whilst techni- In adults and older children the commonest ques such as positron emission tomography (PET) causative organisms are Neisseria meningitidis and are mainly research orientated at present, they may Streptococcus pneumoniae and the treatment of soon find wider clinical application. New electro- choice in the UK is intravenous benzyl penicillin, physiological examinations such as magnetic brain with chloramphenicol as a second line agent. In stimulation have found use in the investigation of children aged 4 months to 6 years the most likely central motor conduction pathways. The applica- organism is Haemophilus influenzae type b which copyright. tion of the techniques of molecular biology to the may be resistant to ampicillin. Initial treatment in study of neurological disease is having a profound this age group has been chloramphenicol and effect on our understanding of the mechanisms ampicillin until sensitivities are known, but Peltona underlying these diseases.
    [Show full text]
  • The ICD-10 Classification of Mental and Behavioural Disorders Diagnostic Criteria for Research
    The ICD-10 Classification of Mental and Behavioural Disorders Diagnostic criteria for research World Health Organization Geneva The World Health Organization is a specialized agency of the United Nations with primary responsibility for international health matters and public health. Through this organization, which was created in 1948, the health professions of some 180 countries exchange their knowledge and experience with the aim of making possible the attainment by all citizens of the world by the year 2000 of a level of health that will permit them to lead a socially and economically productive life. By means of direct technical cooperation with its Member States, and by stimulating such cooperation among them, WHO promotes the development of comprehensive health services, the prevention and control of diseases, the improvement of environmental conditions, the development of human resources for health, the coordination and development of biomedical and health services research, and the planning and implementation of health programmes. These broad fields of endeavour encompass a wide variety of activities, such as developing systems of primary health care that reach the whole population of Member countries; promoting the health of mothers and children; combating malnutrition; controlling malaria and other communicable diseases including tuberculosis and leprosy; coordinating the global strategy for the prevention and control of AIDS; having achieved the eradication of smallpox, promoting mass immunization against a number of other
    [Show full text]
  • Reviving the Diagnosis of Neurasthenia"
    Psychological Medicine, 1997, 27, 989–994. Printed in the United Kingdom # 1997 Cambridge University Press EDITORIAL Reviving the diagnosis of neurasthenia" ‘Whether or not it is worthwhile to distinguish between ‘‘neurasthenia’’ and ‘‘dysthymic disorders’’ must depend either on the demonstration that such syndromes have different social covariates, or pursue a different course, or have particular responses to treatment. Until such studies are forthcoming, the distinction seems especially insubstantial.’ (Goldberg & Bridges, 1991) Epidemiological studies now indicate that fatigue is one of the most common symptoms of ill-health in the community, primary care and other medical settings, and that syndromal diagnoses based on fatigue (including chronic fatigue and neurasthenia) are prevalent and major sources of health care utilization. Such syndromes are characterized by a combination of persistent and disabling fatigue and neuropsychological and neuromuscular symptoms (Lloyd et al. 1990; Angst & Koch, 1991; Sharpe et al. 1991; Fukuda et al. 1994). Essentially, the differences between these syndromes reflect variations in duration criteria rather than symptom constructs. Specifically, the Centers for Disease Control (CDC) defines ‘prolonged fatigue’ as a syndrome of at least 1 month’s duration, and chronic fatigue (including idiopathic and chronic fatigue syndrome – CFS) as a fatigue syndrome of at least 6 months duration (Fukuda et al. 1994). The ICD-10 classification system (World Health Organization, 1992) now includes a formal diagnosis of neurasthenia (F48.0) based on mental and physical fatigue of at least 3 months duration. Despite the current international and epidemiological interest in these disorders, DSM-IV has simply included them within the ‘Undifferentiated Somatoform Disorders – 300.81’ category (American Psychiatric Association, 1994).
    [Show full text]
  • Fatigue Syndrome: Neurasthenia Revived
    result in uneven steering.9 If the tyres are deflated or 9 Goodwill CJ. Wheelchairs. In: Goodwill Cj, Chamberlain MA, eds. Rehabilitation ofthe physically disabled adult. London: Croom Helm, 1988:701-23. punctured the brakes (which work by a plate being pushed or 10 Harris A, Cox E, Smith CRW. Handicapped and impaired in Great Bnrtain. Part 1. London: HMSO, 1971. pulled against the outer edge of the tyre) are ineffective, and 11 Platts EA. Wheelchair design -survey of users' views. Proceedings ofthe Royal Society ofMedicine hence the wheelchair may move when patients get up or sit 1974;67:414-6. 12 Abel EW. Survey of attendant propelled mobile chairs used in hospitals. Health Bull (Edinb) down, causing them to fall. 1983;41:275-7. Failure ofbrakes caused by faults in the braking mechanism 13 Bossingham DH. Wheelchairs and appliances. Clinics in Rheumatic Diseases 1981;7:395-415. 14 Jay P. Choosing the best wheelchair cushion. London: Royal Association for Disability and has been shown in almost two thirds ofhospital wheelchairs in Rehabilitation, 1984. Leeds and Wessex.47 Many wheelchair brakes are crude 15 Penn ND, Belfield PW, Young JB, Whitley AJ, Mulley GP, Mascie-Taylor BH. No more flat tvres: a trial of a tyre insert for wheelchairs. Clinical Rehabilitation (in press). devices, which work loose and need constant adjustment.6 A 16 McLaurin C. Wheelchair development, standards, progress and issues. Rehabil Res Dev quarter ofwheelchair users at find to 1986;23:48-5 1. home the brakes difficult 17 Feeney RJ. Are aids for the disabled consumer goods? In: Bray J, Wright S, eds.
    [Show full text]
  • Neurasthenia at Mengo Hospital, Uganda: a Case Study in Psychiatry and a Diagnosis, 1906–50
    The Journal of Imperial and Commonwealth History ISSN: 0308-6534 (Print) 1743-9329 (Online) Journal homepage: http://www.tandfonline.com/loi/fich20 Neurasthenia at Mengo Hospital, Uganda: A case study in psychiatry and a diagnosis, 1906–50 Yolana Pringle To cite this article: Yolana Pringle (2016): Neurasthenia at Mengo Hospital, Uganda: A case study in psychiatry and a diagnosis, 1906–50, The Journal of Imperial and Commonwealth History, DOI: 10.1080/03086534.2015.1123975 To link to this article: http://dx.doi.org/10.1080/03086534.2015.1123975 © 2016 The Author(s). Published by Taylor & Francis. Published online: 11 Jan 2016. Submit your article to this journal Article views: 66 View related articles View Crossmark data Full Terms & Conditions of access and use can be found at http://www.tandfonline.com/action/journalInformation?journalCode=fich20 Download by: [University of Cambridge] Date: 27 March 2016, At: 06:16 THE JOURNAL OF IMPERIAL AND COMMONWEALTH HISTORY, 2016 http://dx.doi.org/10.1080/03086534.2015.1123975 Neurasthenia at Mengo Hospital, Uganda: A case study in psychiatry and a diagnosis, 1906–50 Yolana Pringle Centre for Research in the Arts, Social Sciences and Humanities (CRASSH), University of Cambridge, Cambridge, UK ABSTRACT KEYWORDS This article uses a case-study approach to examine the Psychiatry; empire; Uganda; complex and contradictory nature of diagnoses like neurasthenia; mission neurasthenia in colonial Africa. Drawing on the case notes medicine; detribalisation of European and African patients diagnosed with neurasthenia at the Church Missionary Society’s Mengo Hospital, Uganda, it argues that in practice, and outside the colonial asylum in particular, ideas about race and mental illness were more nuanced than histories of psychiatry and empire might imply.
    [Show full text]
  • Hypoactive Sexual Desire Disorder in Females
    Running head: FEMALE HYPOACTIVE SEXUAL DESIRE DISORDER 1 Female Hypoactive Sexual Desire Disorder A Summary Paper Presented to The Faculty of the Adler Graduate School ___________________ In Partial Fulfillment of the Requirements for the Degree of Master of Arts in Adlerian Counseling and Psychotherapy __________________ By: Mera Le Colling October 2011 FEMALE HYPOACTIVE SEXUAL DESIRE DISORDER 2 Abstract Hypoactive sexual desire disorder is the most prevalent sexual disorder in women, and one of the most challenging to overcome. This paper discusses the current definition for HSDD, the prevalence of HSDD in women, definitions of sexual health and sexual desire, sexual myths and HSDD, and criticisms around creating sexual norms and ideals related to HSDD. This paper will also discuss physical vs. psychological arousal in women, physical, psychological, and relational aspects of HSDD, male HSDD, an Adlerian perspective of HSDD, theories of desire, and proposed definitions of female HSDD including a proposed DSM-V revision of HSDD. Treatment options discussed include hormonal, antidepressant, herbal, CBT, and mindfulness. FEMALE HYPOACTIVE SEXUAL DESIRE DISORDER 3 Acknowledgments I would like to thank Professor Jere Truer for his guidance and encouragement in the selection of my master’s project. I would also like to thank Earl Heinrich for his ongoing assistance throughout my time at Adler Graduate School. Herb Laube, as both my master’s project reader and as my instructor in many classes, did much to mold my interest in psychology and human sexuality. I also wish to acknowledge the role my family played in my education, specifically Henrietta Truh and Lois Truh, my maternal grandmother and mother.
    [Show full text]
  • Energy, Aging, and Neurasthenia
    Andersen | 47 Energy, Aging, and Neurasthenia A Historical Perspective Michael Andersen University of Copenhagen Author contact: [email protected] Abstract That there is an association between energy and aging may seem commonsensical in modern society. Nonetheless, the question of how aging came to be associated with energy is less well known. This article explores how the 19th century disease of neurasthenia became related to aging through contemporaneous ideas about productivity, energy surplus and energy dissipation based on an analysis of how a lack of energy was featured as a symptom of the disease. It examines the specific historical intersection where a lack of energy was related to a diagnosis, illustrates how aging and energy have become intrinsically tied to each other and how the focus on the productive uses of energy has antecedents in religion as well as moral economics. As aging continues to be considered a problem in modern society--in large part due to the inherent unproductivity associated with old age caused by a lack of energy--the discourses surrounding neurasthenia demonstrate how the concept of energy manifested itself in contemporaneous consciousness. Keywords: aging; disease; neurasthenia; energy Anthropology & Aging, Vol 40, No 2 (2019), pp. 48-59 ISSN 2374-2267 (online) DOI 10.5195/aa.2019.170 This work is licensed under a Creative Commons Attribution 4.0 International License. This journal is published by the University Library System of the University of Pittsburgh as part of its D-Scribe Digital Publishing Program, and is cosponsored by the University of Pittsburgh Press. Anthropology & Aging Vol 40, No 2 (2019) ISSN 2374-2267 (online) DOI 10.5195/aa.2019.170 http://anthro-age.pitt.edu Andersen | 48 Energy, Aging, and Neurasthenia A Historical Perspective Michael Andersen University of Copenhagen Author contact: [email protected] Introduction An old story often told is that the human body is a phenomenon that inevitably ages.
    [Show full text]
  • Psychological and Behavioral Therapies
    Supplementary File 1: Psychological and behavioral therapies Behavior Therapy / Behavior Modification Cognitive Behavioral Therapy Activity Scheduling Problem Solving Assertiveness Training Rational Emotive Therapy Aversion Therapy Reality Therapy Behavior Contracting Restructuring Behavior Modification Role Play Biofeedback, Psychology Schemas Contingency Management Self-Control Conversion Therapy Stress Management Distraction Therapy Exposure Therapy Pleasant Events Psychoeducation Problem-Focused Reciprocal Inhibition Therapy Relaxation Techniques Response Cost Sleep Phase Chronotherapy Social Skills Training Psychodynamic Therapies Third Wave Cognitive Behavioral Therapies Brief Psychotherapy Acceptance And Commitment Therapy (ACT) Countertransference Behavioral Activation Freudian Cognitive Behavioral Analysis System Of Group Therapy Psychotherapy (CBASP) Insight Oriented Therapy Compassion-Focused Jungian Dialectical Behavior Therapy Kleinian Diffusion Object Relations Functional Analytic Psychotherapy (FAP) Person Centered Therapy, Client-Centered Metacognitive Therapy Therapy Mind Training Psychoanalytic Therapy Mindfulness Short-Term Psychotherapy Transference Humanistic Therapies Integrative Therapies Existential Therapy Cognitive Analytical Therapy Experiential Therapy Counselling Expressive Therapy Eclectic Therapy Griefwork Interpersonal Therapy Rogerian Multimodal Non-Directive Therapy Transtheoretical Supportive Therapy Transactional Analysis Systemic Therapies
    [Show full text]
  • Treatment of Anxiety Disorders in Clinical Practice: a Critical Overview of Recent Systematic Evidence
    REVIEW ARTICLE Treatment of anxiety disorders in clinical practice: a critical overview of recent systematic evidence Vitor Iglesias Mangolini0000-0000-0000-0000 ,I,II Laura Helena Andrade0000-0000-0000-0000 ,II Francisco Lotufo-Neto0000-0000-0000-0000 ,II Yuan-Pang Wang0000-0000-0000-0000 II,* I Faculdade de Medicina FMUSP, Universidade de Sao Paulo, Sao Paulo, SP, BR. II Departamento de Psiquiatria, Instituto de Psiquiatria, LIM-23, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, BR. Mangolini VI, Andrade LH, Lotufo-Neto F, Wang YP. Treatment of anxiety disorders in clinical practice: a critical overview of recent systematic evidence. Clinics. 2019;74:e1316 *Corresponding author. E-mail: [email protected] The aim of this study was to review emerging evidence of novel treatments for anxiety disorders. We searched PubMed and EMBASE for evidence-based therapeutic alternatives for anxiety disorders in adults, covering the past five years. Eligible articles were systematic reviews (with or without meta-analysis), which evaluated treatment effectiveness of either nonbiological or biological interventions for anxiety disorders. Retrieved articles were summarized as an overview. We assessed methods, quality of evidence, and risk of bias of the articles. Nineteen systematic reviews provided information on almost 88 thousand participants, distributed across 811 clinical trials. Regarding the interventions, 11 reviews investigated psychological or nonbiological treatments; 5, pharmacological or biological; and 3, more than one type of active intervention. Computer- delivered psychological interventions were helpful for treating anxiety of low-to-moderate intensity, but the therapist-oriented approaches had greater results. Recommendations for regular exercise, mindfulness, yoga, and safety behaviors were applicable to anxiety.
    [Show full text]